Cargando…

The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers

There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using les...

Descripción completa

Detalles Bibliográficos
Autores principales: Grande, Carolyn, Visovsky, Constance, Brose, Marcia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040873/
https://www.ncbi.nlm.nih.gov/pubmed/30018844
_version_ 1783338903430758400
author Grande, Carolyn
Visovsky, Constance
Brose, Marcia S.
author_facet Grande, Carolyn
Visovsky, Constance
Brose, Marcia S.
author_sort Grande, Carolyn
collection PubMed
description There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using less traditional approaches.
format Online
Article
Text
id pubmed-6040873
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-60408732018-07-17 The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers Grande, Carolyn Visovsky, Constance Brose, Marcia S. J Adv Pract Oncol Review Article There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using less traditional approaches. Harborside Press 2017 2017-05-01 /pmc/articles/PMC6040873/ /pubmed/30018844 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Grande, Carolyn
Visovsky, Constance
Brose, Marcia S.
The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title_full The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title_fullStr The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title_full_unstemmed The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title_short The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
title_sort challenges of clinical research in rare cancers: bevacizumab use in low-grade serous ovarian and primary peritoneal cancers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040873/
https://www.ncbi.nlm.nih.gov/pubmed/30018844
work_keys_str_mv AT grandecarolyn thechallengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers
AT visovskyconstance thechallengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers
AT brosemarcias thechallengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers
AT grandecarolyn challengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers
AT visovskyconstance challengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers
AT brosemarcias challengesofclinicalresearchinrarecancersbevacizumabuseinlowgradeserousovarianandprimaryperitonealcancers